A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia
Dermatologists are reporting an increase in patients with these concerns, and influencers on TikTok and Instagram are pushing a variety of products geared toward this segment of consumers
Lenzi A, Sgro P, Salacone P, Paoli D, Gilio B, Lombardo F, et al
Anti-Aging: It fights free radicals, reducing oxidative stress, which helps slow down aging and enhances skins elasticity
FDA Press Release on First Treatment for Menkes Disease Rare Disease: FDA Expands Treatment Approval for Gaucher Disease The FDA expanded the approval of Sanofis Cerezyme (imiglucerase) intravenous infusion enzyme replacement therapy to treat non-neurological symptoms in patients with Type 3 Gaucher disease, which is the rarest and most serious type